Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4505194, 10 pages
https://doi.org/10.1155/2017/4505194
Review Article

Review on Research about Traditional Chinese Medicine in Cancer Stem Cell

1Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medicine Sciences, No. 5 Beixiange, Xicheng District, Beijing 100053, China
2Traditional Chinese Medicine Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China

Correspondence should be addressed to Li Feng; moc.621@366ilgnef, Bingkui Piao; moc.361@321iukgniboaip, and Peitong Zhang; moc.liamtoh@gnotiepgnahzrd

Received 5 February 2017; Revised 23 May 2017; Accepted 15 June 2017; Published 4 October 2017

Academic Editor: Shuang-En Chuang

Copyright © 2017 Yaohan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 1, pp. 105–111, 2001. View at Google Scholar
  2. C. T. Jordan, M. L. Guzman, and M. Noble, “Cancer stem cells,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1253–1261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Dick, “Human acut emyeloid leukemia is organize dasahierarchy that originates from aprimitive hematopoietic cell,” Nature Med, vol. 3, pp. 730–737, 1997. View at Google Scholar
  4. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Takaishi, T. Okumura, S. Tu et al., “Identificationofgastriccancerstemcells using thecellsurfacemarkerCD44,” Stem cells, vol. 27, no. 5, pp. 1006–1020, 2009. View at Google Scholar
  6. K. Polyak and W. C. Hahn, “Roots and stems: Stem cells in cancer,” Nature Medicine, vol. 12, no. 3, pp. 296–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Eaves, “Cancer stem cells: Here, there, everywhere?” Nature, vol. 456, no. 7222, pp. 581-582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. N. Almanaa, M. E. Geusz, and R. J. Jamasbi, “A New Method for Identifying Stem-Like Cells in Esophageal Cancer Cell Lines,” Journal of Cancer, vol. 4, no. 7, pp. 536–548, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Clarke, J. E. Dick, P. B. Dirks et al., “Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells,” Cancer Research, vol. 66, no. 19, pp. 9339–9344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. D. Girouard and G. Murphy, “Melanoma stem cells: not rare, but well done,” Lab Invest, vol. 91, no. 5, pp. 647–664, 2011. View at Google Scholar
  11. “The cancer stem cell hypothesis: failures and pitfalls,” Neurosurgery, vol. 68, no. 2, pp. 531–545, 2011.
  12. B. B. Tysnes and R. Bjerkvig, “Cancer initiation and progression: involvement of stem cells and the microenvironment, BBARev,” Cancer, vol. 1775, no. 2, pp. 283–297, 2007. View at Google Scholar
  13. W. Guo, J. L. Lasky, and H. Wu, “Cancer stem cells,” Pediatric Research, vol. 59, no. 4 Pt 2, pp. 59R–64R, 2006. View at Google Scholar
  14. C. T. Jordan, “Cancer stem cell biology: From leukemia to solid tumors,” Current Opinion in Cell Biology, vol. 16, no. 6, pp. 708–712, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Pathak, “Organ-and tissue-specific stem cells and careinogenesis,” Anti-cancer Res, vol. 22, no. 3, pp. 1353–1356, 2002. View at Google Scholar
  16. J. Zheng, “Cellular and molecular biology cancer,” Shanghai: Shanghai Science and Technology Press, pp. 150–167, 2011. View at Google Scholar
  17. J. Zhang, Z. W. Xu, S. H. Du et al., “Stem cells and the theory of “Essence”,” Study Journal of Traditional Chinese Medicine, vol. 22, no. 7, pp. 1198–1200, 2004. View at Google Scholar
  18. P. Y. Liu and G. X. Cai, “The relationship between Essence and stem cell in biology,” Journal of Hunan College of Traditional Chinese Medicine, vol. 23, no. 6, pp. 29-30, 2003. View at Google Scholar
  19. D. S. Xiao, L. D. Yu, G. Y. Yu et al., “The relationship five elements and stem cells,” Zhejiang Journal of Tradition Chiese medicine, vol. 42, no. 11, pp. 669–671, 2007. View at Google Scholar
  20. Z. W. Xu, J. Zhang, and M. Zhang, “Stem cell transplantation to treat ischemic heart failure based on heart and kidney related,” Journal of Yunnan University of Traditional Chinese Medicine, no. 5, p. 14, 2009. View at Google Scholar
  21. W.-R. Xu, H.-S. Lin, X.-Y. Chen, and Y. Zhang, “Yin-yang balance therapy on regulating cancer stem cells,” Journal of Traditional Chinese Medicine, vol. 31, no. 2, pp. 158–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ye and J. Shi, “The relationship between phlegm and tumor stem cells in traditional Chinese Medicine,” China Medical Herald, vol. 13, no. 28, pp. 80–94, 2016. View at Google Scholar
  23. B. Yan, Z. F. Qin, and P. K. Wei, “The theory of phlegm and gastric cancer stem cells,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 19, no. 7, pp. 93–95, 2012. View at Google Scholar
  24. T. Lapidot, C. Sirard, J. Vormoor et al., “A cell initiating human acute myeloid leukaemia after transplantation into SCID mice,” Nature, vol. 367, no. 6464, pp. 645–648, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. O'Brien, A. Pollett, S. Gallinger, and J. E. Dick, “A human colon cancer cell capable of initiating tumour growth in immunodeficient mice,” Nature, vol. 445, no. 7123, pp. 106–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi et al., “Identification and expansion of human colon-cancer-initiating cells,” Nature, vol. 445, no. 7123, pp. 111–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Dean, T. Fojo, and S. Bates, “Tumour stem cells and drug resistance,” Nature Reviews Cancer, vol. 5, no. 4, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. B.-B. S. Zhou, H. Zhang, M. Damelin, K. G. Geles, J. C. Grindley, and P. B. Dirks, “Tumour-initiating cells: challenges and opportunities for anticancer drug discovery,” Nature Reviews Drug Discovery, vol. 8, no. 10, pp. 806–823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Wei, P. Chen, Y. Chen, A. Shen et al., “Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells,” Molecular Medicine Reports, vol. 9, pp. 261–266, 2014. View at Google Scholar
  31. T. Efferth, “Stem cells, cancer stem-like cells, and natural products,” Planta Medica, vol. 78, no. 10, pp. 935–942, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Yahua, Y. Xue, X. Haolun, Y. Helu, L. Xia, and T. Hui, “The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals,” International Journal of Nanomedicine, vol. 12, pp. 1369–1384, 2017. View at Google Scholar
  33. P. R. Pandey, H. Okuda, M. Watabe et al., “Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase,” Breast Cancer Research and Treatment, vol. 130, no. 2, pp. 387–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Chang, Y. Zhao, W. Gu et al., “Bufalin inhibits the differentiation and proliferation of cancer stem cells derived from primary osteosarcoma cells through Mir-148a,” Cellular Physiology and Biochemistry, vol. 36, no. 3, pp. 1186–1196, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. R. K. Srivastava, S. N. Tang, W. Zhun et al., “Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells,” Front Biosci, vol. 1, no. 3, pp. 515–528, 2011. View at Google Scholar
  36. Y. Zhang, “cal behavior of cancer stem cell like cells in human breast cancer MCF-7 cell line,” China Academy of Chinese medical Science, vol. 4, 2009. View at Google Scholar
  37. Y. R. Shi, H. Xu, M. Y. Shi et al., “Hedyotisdiffusa willd inhibit colon cancer stem cells differentiation by Wnt pathway,” Pharmacology and Clinics of Chinese Materia Medica, vol. 31, no. 1, pp. 133–136, 2015. View at Google Scholar
  38. K.-Q. Han, G. Huang, W. Gu, Y.-H. Su, X.-Q. Huang, and C.-Q. Ling, “Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice,” World Journal of Gastroenterology, vol. 13, no. 24, pp. 3374–3379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Watabe, K. Ito, Y. Masuda, S. Nakajo, and K. Nakaya, “Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells,” Oncogene, vol. 16, no. 6, pp. 779–787, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-Y. Yeh, W. J. Huang, S.-F. Kan, and P. S. Wang, “Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells,” Prostate, vol. 54, no. 2, pp. 112–124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Li, X. Qu, K. Hou et al., “PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells,” Anti-Cancer Drugs, vol. 20, no. 1, pp. 59–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Kaushik, D. Kwatra, D. Subramaniam, R. A. Jensen, S. Anant, and J. M. V. Mammen, “Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway,” American Journal of Surgery, vol. 208, no. 6, pp. 995–1002, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Yang, J. Chen, J. Yi et al., “Induction effect of realgar nanoparticles on lung cancer A549 cells and cancer stem cell apoptosis,” Pharmacology and Clinics of Chinese Materia Medica, vol. 26, no. 6, p. 39, 2010. View at Google Scholar
  44. L.-C. Lin, C.-T. Yeh, C.-C. Kuo et al., “Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function,” Journal of Agricultural and Food Chemistry, vol. 60, no. 28, pp. 7031–7039, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Li, “Effect of Sijunzitang on proliferation and apoptosis of gastric cancer side populationcells,” Beng Bu Medcine, vol. 5, 2013. View at Google Scholar
  46. S. Wang, L. F. Wang, Z. Y. Xu et al., “The effect of Feiyanning on Wnt pathway in lung cancer stem cells,” Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai, vol. 26, no. 6, pp. 77–82, 2012. View at Google Scholar
  47. S.-F. Kan, C.-H. Yu, H.-F. Pu, J.-M. Hsu, M.-J. Chen, and P. S. Wang, “Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3,” Journal of Cellular Biochemistry, vol. 101, no. 1, pp. 44–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Han, J. K. Woo, Y. Jung et al., “Evodiamine selectively targets cancer stem-like cells through the p53-p21-Rb pathway,” Biochemical and Biophysical Research Communications, vol. 469, no. 4, pp. 1153–1158, 2016. View at Publisher · View at Google Scholar
  49. Q. Y. Fan, “Effect of Yiqijiedu formula on cell cycle and cancer stem cell marker CD44 and ABCG2 expression in nasopharyngeal carcinomaCNE2,” Hu Nan University of Traditional Chinese Medicine, vol. 5, 2013. View at Google Scholar
  50. L. Lin, Y. Liu, H. Li et al., “Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030,” British Journal of Cancer, vol. 105, no. 2, pp. 212–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Wang, T. Zhang, L. Liu et al., “Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells,” International Journal of Nanomedicine, vol. 7, pp. 4487–4497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. S.-H. Li, J. Fu, D. N. Watkins, R. K. Srivastava, and S. Shankar, “Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway,” Molecular and Cellular Biochemistry, vol. 373, no. 1-2, pp. 217–227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Shankar, D. Nall, S.-N. Tang et al., “Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition,” PLoS ONE, vol. 6, no. 1, Article ID e16530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. Q. Zhou, M. Ye, Y. Lu et al., “Curcumin improves the tumoricidal effect of mitomycin C by suppressing ABCG2 expression in stem cell-like breast cancer cells,” PLoS ONE, vol. 10, no. 8, Article ID e0136694, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Shen, J. Lin, and Y. Chen, “Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways,” Oncology Reports, vol. 30, no. 4, pp. 1701–1706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Shen, Y. Chen, F. Hong et al., “Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3,” Oncology Reports, vol. 28, no. 6, pp. 2125–2130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. Q. Zhuang, F. Hong, A. Shen et al., “Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model,” International Journal of Oncology, vol. 40, no. 5, pp. 1569–1574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Levine and D. J. Klionsky, “Development by self-digestion: Molecular mechanisms and biological functions of autophagy,” Developmental Cell, vol. 6, no. 4, pp. 463–477, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. X. H. Pan, X. L. Zhang, H. L. Sun, J. Zhang, M. Yan, and H. Zhang, “Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells,” PLoS ONE, vol. 8, no. 2, Article ID e56679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Ravikumar, C. Vacher, Z. Berger et al., “Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease,” Nature Genetics, vol. 36, no. 6, pp. 585–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. T. T. Mai, J. Moon, Y. Song et al., “Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells,” Cancer Letters, vol. 321, no. 2, pp. 144–153, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. J.-M. Liu, B.-Y. Mao, S. Hong, Y.-H. Liu, and X.-J. Wang, “The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence,” Advances in Therapy, vol. 25, no. 5, pp. 389–398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. M. Liu, L. W. Huang, P. Hu et al., “Effects of Chinese herbs for activating blood circulation and removing stasis on invasion ability and TIMP1 mRNA expression of C6 brain tumor stem cells,” Journal of New Chinese medicine, vol. 43, no. 8, pp. 192–194, 2013. View at Google Scholar
  66. W. T. Zhang, “Study on the effect of five kinds of traditional Chinese medicine on the tumorigenicity of human breast cancer stem cell,” Guangxi Medicine University, 2012. View at Google Scholar
  67. M. P. Shi, B. S. Zhong, L. Y. Gao et al., “Wu San Granule inhibit nucleic acidin malignant tumor cells in vitro,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 23, pp. 142-143, 2003. View at Google Scholar
  68. J. Yang, Z. Fang, J. Wu et al., “Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine,” Tumor Biology, vol. 37, no. 10, pp. 13871–13883, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Sun, L. Wei, J. Feng, J. Lin, and J. Peng, “Inhibitory effects of hedyotis diffusa willd. On colorectal cancer stem cells,” Oncology Letters, vol. 11, no. 6, pp. 3875–3881, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Li, T. Zhang, H. Korkaya et al., “Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells,” Clinical Cancer Research, vol. 16, no. 9, pp. 2580–2590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Sun, “Study on MCF-7cell enrichment and identification and intervention of brucine on breast cancer stem cells,” Anhui Medical University, 2012. View at Google Scholar
  72. W. Wenlong, Z. Chongqiang, and J. David, “Ursolic Acid Inhibits the Growth of Colon Cancer-initiating Cells by Targeting STAT3,” Anticancer Research, vol. 33, pp. 4279–4284, 2013. View at Google Scholar
  73. J. Zhang, W. Wang, L. Qian, Q. Zhang, D. Lai, and C. Qi, “Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition,” Oncology Reports, vol. 34, no. 5, pp. 2375–2384, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Qi, L. Wei, A. Shen et al., “Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway,” Oncology Reports, vol. 35, no. 1, pp. 511–517, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. Z.-G. Yang, H.-X. Sun, and Y.-P. Ye, “Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis,” Chemistry and Biodiversity, vol. 3, no. 2, pp. 187–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Q. Zhang, “Effect of Scutellaria Decoction on proliferation of gastric cancer stem cells in vitro,” Fujian Universty of Traditional Medicine, 2014. View at Google Scholar
  77. Y. Wang, P. Zhang, D. Yang et al., “Effect of Ligustrazine, TanshinoneIIA on aposis of PG stem like cells,” Liaoning Journal of Traditional Chinese Medicine, vol. 5, no. 45, pp. 1024–1028, 1120-1121, 2016. View at Google Scholar
  78. Y. R. Zhang, “Research on the mechanism of prevention breast cancer metastasis by Fuzheng Qudu and its monomer composition of peimine inhibiting breast cancer stem cells epithelial mesenchymal transition,” Beijing University of Chinese Traditional Medicine, 2014. View at Google Scholar
  79. B. N. Singh, D. Kumar, S. Shankar, and R. K. Srivastava, “Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells,” Biochemical Pharmacology, vol. 84, no. 9, pp. 1154–1163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. Z. Y. Cao, X. Z. Chen, Y. Lin et al., “Effects of Chinese medicine on the expression of c-kit and CD133 in cancer stem cells of mice with hepatocellular carcinoma,” Journal of Fujian College of Traditional Chinese Medicine, vol. 2010, no. 3, pp. 18–20, 2010. View at Google Scholar
  81. Y. Y. Luo, “Effects of Ginsenoside on invasion and the expression of CD133 in gastric cancer bearing nude mice,” Nanjing University of Traditional Chinese Medicine, 2014. View at Google Scholar
  82. W. Xu, B. G. Debeb, L. Lacerda, J. Li, and W. A. Woodward, “Tetrandrine, a compound common in Chinese traditional medicine, preferentially kills breast cancer tumor initiating cells (TICs) in vitro,” Cancers, vol. 3, no. 2, pp. 2274–2285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. D. Yang, P. Zhang, Y. Wang et al., “Effect of Ligustrazine on adhesion of PG-BE1 Stem Like Cells in the Pulmonary Giant Cell Carcinoma of Human with High Metastatic Lung Cancer,” Journal of Traditional Chinese Medicine, vol. 56, no. 13, pp. 1140–1144, 2015. View at Google Scholar
  84. D. Yang, P. Zhang, Y. Wang et al., “Effect of TMP on the Expression of VEGF and HIF-1α of PG CSC Like Cells,” China Cancer, vol. 24, no. 3, pp. 234–240, 2015. View at Google Scholar
  85. D. Yang, “Study about the effect of malignant biological characteristics of stem like cells by tetramethylprazine and tansfflnoneIIA, Beijing,” China Academy of Chinese Medical Science, 2015. View at Google Scholar
  86. P. W. Ingham and A. P. McMahon, “Hedgehog signaling in animal development: paradigms and principles,” Genes & Development, vol. 15, pp. 3059–3087, 2001. View at Google Scholar
  87. X. Lu, H. Xu, M. Shi et al., “Sculellaria barbata inhibit colon cancer stem cells self-renew by Hedgehog pathway,” Pharmacology and Clinics of Chinese Materia Medica, vol. 31, no. 1, pp. 139–141, 2015. View at Google Scholar
  88. C. Karamboulas and L. Ailles, “Developmental signaling pathways in cancer stem cells of solid tumors,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1830, no. 2, pp. 2481–2495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Kumazoe, M. Takai, S. Hiroi et al., “FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma,” Journal of Biological Chemistry, vol. 292, no. 26, pp. 10813–10823, 2017. View at Publisher · View at Google Scholar
  90. D.-D. Xu, P.-J. Zhou, Y. Wang et al., “Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway,” Molecular Cancer, vol. 15, no. 1, article no. 40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  91. S. L. Tung, W. C. Huang, F. C. Hsu et al., “miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway,” Oncogenesis, vol. 6, article e326, no. 5, 2017. View at Google Scholar
  92. E. Fessler, F. E. Dijkgraaf, F. De Sousa E Melo, and J. P. Medema, “Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?” Cancer Letters, vol. 341, no. 1, pp. 97–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. M. C. Cabrera, R. E. Hollingsworth, E. M. Hurt et al., “Cancer stem cell plasticity and tumor hierarchy,” World Journal of Stem Cells, vol. 7, pp. 27–36, 2015. View at Google Scholar